These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 2849669)

  • 1. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
    Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
    Carter CJ; Lloyd KG; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1990 May; 253(2):475-82. PubMed ID: 1971016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.
    Gotti B; Duverger D; Bertin J; Carter C; Dupont R; Frost J; Gaudilliere B; MacKenzie ET; Rousseau J; Scatton B
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1211-21. PubMed ID: 2849668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.
    Baron BM; Dudley MW; McCarty DR; Miller FP; Reynolds IJ; Schmidt CJ
    J Pharmacol Exp Ther; 1989 Jul; 250(1):162-9. PubMed ID: 2545857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for native NMDA receptor subtype pharmacology as revealed by differential effects on the NMDA-evoked release of striatal neuromodulators: eliprodil, ifenprodil and other native NMDA receptor subtype selective compounds.
    Nankai M; Klarica M; Fage D; Carter C
    Neurochem Int; 1996 Nov; 29(5):529-42. PubMed ID: 8939463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ifenprodil on the N-methyl-D-aspartate receptor ionophore complex in rat brain.
    Ogita K; Ohkawara A; Suzuki T; Ohgaki T; Uchida S; Meguri H; Yoneda Y
    Neurochem Int; 1992 Jul; 21(1):135-47. PubMed ID: 1363860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists.
    Willetts J; Balster RL
    J Pharmacol Exp Ther; 1989 May; 249(2):438-43. PubMed ID: 2542531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative autoradiographic localization of NMDA receptors in rat brain using [3H]CPP: comparison with [3H]TCP binding sites.
    Jarvis MF; Murphy DE; Williams M
    Eur J Pharmacol; 1987 Sep; 141(1):149-52. PubMed ID: 2822443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CGS 19755 is a potent and competitive antagonist at NMDA-type receptors.
    Lehmann J; Chapman AG; Meldrum BS; Hutchison A; Tsai C; Wood PL
    Eur J Pharmacol; 1988 Sep; 154(1):89-93. PubMed ID: 2846329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
    Coughenour LL; Cordon JJ
    J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-((+/-)2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) more potently antagonizes the high-affinity Mg2+ binding site on the N-methyl-D-aspartate/phencyclidine receptor ion channel complex than the L-glutamate recognition site.
    Hatta K; Yamamato T; Hori T; Okuwa M; Moroji T
    Neurosci Lett; 1991 Apr; 124(2):229-31. PubMed ID: 1712440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites.
    Rothman RB; Reid AA; Monn JA; Jacobson AE; Rice KC
    Mol Pharmacol; 1989 Dec; 36(6):887-96. PubMed ID: 2557536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex.
    Loo PS; Braunwalder AF; Lehmann J; Williams M; Sills MA
    Mol Pharmacol; 1987 Dec; 32(6):820-30. PubMed ID: 2892125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that zinc inhibits N-methyl-D-aspartate receptor-gated ion channel activation by noncompetitive antagonism of glycine binding.
    Yeh GC; Bonhaus DW; McNamara JO
    Mol Pharmacol; 1990 Jul; 38(1):14-9. PubMed ID: 1695316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological properties of the N-methyl-D-aspartate receptor system coupled to the evoked release of gamma-[3H] aminobutyric acid from striatal neurons in primary culture.
    Weiss S
    J Pharmacol Exp Ther; 1990 Jan; 252(1):380-6. PubMed ID: 1967648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.
    Baron BM; Harrison BL; Kehne JH; Schmidt CJ; van Giersbergen PL; White HS; Siegel BW; Senyah Y; McCloskey TC; Fadayel GM; Taylor VL; Murawsky MK; Nyce P; Salituro FG
    Eur J Pharmacol; 1997 Apr; 323(2-3):181-92. PubMed ID: 9128837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain.
    Murphy DE; Hutchison AJ; Hurt SD; Williams M; Sills MA
    Br J Pharmacol; 1988 Nov; 95(3):932-8. PubMed ID: 2850065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of [3H]dopamine release from guinea pig striatum by NMDA receptor/channel activators and inhibitors.
    Werling LL; Jacocks HM; McMahon PN
    J Pharmacol Exp Ther; 1990 Oct; 255(1):40-5. PubMed ID: 1698972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
    Willetts J; Balster RL
    J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.